HBV抗原表位特异性细胞毒性T淋巴细胞(cytotoxic T lymphocytes, CTL)应答是机体清除或控制肝细胞内HBV感染的主要机制。病毒蛋白中的CTL表位(epitope)是特异性CTL识别和攻击的目标。
基于96个网页-相关网页
cytotoxic t lymphocytes ctl 细胞毒性t细胞
Specific cytotoxic T lymphocytes 特异性细胞毒性T淋巴细胞
anti-tumor cytotoxic t lymphocytes 抗肿瘤ctl
hiv-specific cytotoxic t lymphocytes 病毒特异性细胞毒性t细胞
immune cytotoxic t lymphocytes 免疫细胞毒细胞
special cytotoxic t lymphocytes 特异性细胞毒性t淋巴细胞
alloreactive cytotoxic T lymphocytes 同种反应性细胞毒T细胞
cytotoxic t lymphocytes related antigen 毒性t淋巴细胞相关抗原
antigen-specific cytotoxic t lymphocytes 抗原特异性细胞毒t细胞
The effects of DCs pulsed with tumoral antigens on cytotoxic T lymphocytes(CTLs) inducement and growth inhibition of YTMLC cells were assayed.
观察肿瘤抗原负载后诱导特异性细胞毒T淋巴细胞生成和对肿瘤细胞杀伤作用。
CD8+ cytotoxic T lymphocytes (CTL) play a critical role in eradicating Plasmodium falciparum at the pre-erythrocyte stage of the parasite infection.
杀伤性T淋巴细胞（CTL）是红细胞前期恶性疟原虫免疫防护的关键环节。
The drug and virus reactivation destroy tissues by an immune allergic reaction. And the destruction is primarily caused by CD8 + cytotoxic t lymphocytes.
药物及病毒再激活引发的免疫过敏反应所致组织损害主要南cd 8 +细胞毒性T淋巴细胞造成。
应用推荐